← Open Payments lookup

STACIE RAMSEY: Open Payments

NPI 1336405455 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$795 in 42 payments from 15 companies in 2025. Trend: 2023 $1,323 · 2024 $612 · 2025 $795

Food & beverage: $795
CompanyPaymentsAmount
Novo Nordisk Inc11$229
ABBVIE INC.11$198
AstraZeneca Pharmaceuticals LP5$82
Janssen Pharmaceuticals, Inc2$42
GlaxoSmithKline, LLC.2$38
Phathom Pharmaceuticals, Inc.2$32
UCB, Inc.1$25
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$24
Abbott Laboratories1$21
Amgen Inc.1$20

Products named: Ozempic, VRAYLAR, AIRSUPRA, QULIPTA, UBRELVY, SPRAVATO, TRELEGY ELLIPTA, VOQUEZNA.

Industry payments across MS — which companies pay providers there.